Inventor
Tirtha Chakraborty
Inventor
Medford, MA, US
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes18%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides14%
C12YEnzymes14%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
C07HSugars7%
Y02ATechnologies for adaptation to climate change7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
11,027,025Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use202110,925,935Terminally Modified RNA202110,849,920Methods for therapeutic administration of messenger ribonucleic acid drugs202010,772,975Modified Polynucleotides for the production of biologics and proteins associated with human disease202010,155,029Terminally modified RNA201810,138,507Manufacturing methods for production of RNA transcripts20189,827,332Modified polynucleotides for the production of proteins20179,828,416Modified polynucleotides for the production of secreted proteins20179,814,760'Modified polynucleotides for the production of biologics and proteins associated with human disease'20179,782,462'Modified polynucleotides for the production of proteins associated with human disease'20179,675,668'Modified polynucleotides encoding hepatitis A virus cellular receptor 2'20179,597,380'Terminally modified RNA'20179,587,003'Modified polynucleotides for the production of oncology-related proteins and peptides'20179,572,897'Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins'20179,572,896'In vivo production of proteins'20179,504,734'Modified polynucleotides for the production of nuclear proteins'20169,301,993'Modified polynucleotides encoding apoptosis inducing factor 1'20169,303,079'Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins'20169,283,287'Modified polynucleotides for the production of nuclear proteins'20169,255,129'Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1'20169,254,311'Modified polynucleotides for the production of proteins'20169,233,141'Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders'20169,220,792'Modified polynucleotides encoding aquaporin-5'20159,221,891'In vivo production of proteins'20159,220,755'Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders'20159,216,205'Modified polynucleotides encoding granulysin'20159,192,651'Modified polynucleotides for the production of secreted proteins'20159,149,506'Modified polynucleotides encoding septin-4'20159,114,113'Modified polynucleotides encoding citeD4'20159,107,886'Modified polynucleotides encoding basic helix-loop-helix family member E41'20159,095,552'Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1'20159,089,604'Modified polynucleotides for treating galactosylceramidase protein deficiency'20159,061,059'Modified polynucleotides for treating protein deficiency'20159,050,297'Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator'20158,999,380'Modified polynucleotides for the production of biologics and proteins associated with human disease'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2017Patents assigned to MODERNA THERAPEUTICS INC (26)· patent assignee history
2015Patents assigned to modeRNA Therapeutics (1)· patent assignee history
2015–2021Based in Medford, MA, US· patent location history
2016–2021Patents assigned to MODERNATX INC (15)· patent assignee history
2021Patents assigned to MODERNA TX INC (1)· patent assignee history
2021Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MODERNA THERAPEUTICS INC | 26 | 2015–2017 |
| MODERNATX INC | 15 | 2016–2021 |
| MODERNA TX INC | 1 | 2021 |
| modeRNA Therapeutics | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Medford, Massachusetts, US | 34 | 2015–2021 |
| Cambridge, Massachusetts, US | 1 | 2021 |